Synthesis of conformationally preorganized and cell-permeable guanidine-based gamma-peptide nucleic acids (gammaGPNAs).
about
Nucleic acid targeting: towards personalized therapy for head and neck cancer.γ Sulphate PNA (PNA S): highly selective DNA binding molecule showing promising antigene activity.Evaluating the effect of ionic strength on duplex stability for PNA having negatively or positively charged side chains.Synthesis and characterization of conformationally preorganized, (R)-diethylene glycol-containing γ-peptide nucleic acids with superior hybridization properties and water solubilityPolyanionic Carboxyethyl Peptide Nucleic Acids (ce-PNAs): Synthesis and DNA BindingPerfluoroalkylchain conjugation as a new tactic for enhancing cell permeability of peptide nucleic acids (PNAs) via reducing the nanoparticle size.Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5Insights on chiral, backbone modified peptide nucleic acids: Properties and biological activity.β,γ-Bis-substituted PNA with configurational and conformational switch: preferred binding to cDNA/RNA and cell-uptake studies.Antitumor effects of EGFR antisense guanidine-based peptide nucleic acids in cancer models.Recognition of double-stranded RNA by guanidine-modified peptide nucleic acids.PNAs grafted with (α/γ, R/S)-aminomethylene pendants: regio and stereo specific effects on DNA binding and improved cell uptake.Improvement of sequence selectivity in triple helical recognition of RNA by phenylalanine-derived PNA.β-Catenin knockdown in liver tumor cells by a cell permeable gamma guanidine-based peptide nucleic acid.Recent advances in chemical modification of Peptide nucleic acids.Sequence-selective recognition of double-stranded RNA and enhanced cellular uptake of cationic nucleobase and backbone-modified peptide nucleic acids.Design of Bivalent Nucleic Acid Ligands for Recognition of RNA-Repeated Expansion Associated with Huntington's Disease.Amidines bearing benzofuroxan or benzimidazole 1,3-dioxide core scaffolds as Trypanosoma cruzi-inhibitors: structural basis for their interactions with cruzipain
P2860
Q26850237-800B1F00-2FE1-4F5D-8209-E1DDAE0B1E90Q34268989-C1AB5514-F755-498E-AA58-FCF074DF09B4Q34618932-92C13815-696D-487C-976D-25B8E200EFCFQ35219222-0476D065-BA09-4069-86FF-68BA76D02754Q35808409-ACAAD395-7BFB-4D50-A6EA-D1CFC2E7C96FQ35831633-24EDA98C-5B16-48A3-AA05-BE309E398D26Q37167989-90DDF8CA-4DE5-4280-A898-72905E70F0C3Q38294395-F219A568-8B94-4390-B873-89E532D4E04FQ38299936-55F0F010-EE69-4A23-A4C9-1EB96422C6B0Q38320343-C3B084B9-F617-4B19-8CF6-B31F47D5617FQ38329694-B052B521-8D04-4FEE-9E03-EA3F890974EBQ38339094-C31D0FD4-1CE8-4EFD-A227-B5424C2102E3Q38401067-856F022C-0860-4364-93E5-7B5879322F6EQ39131067-8D838E4D-D193-4ABC-A84E-863C0597E621Q42325696-8BB635A6-783B-48A1-81DF-44466283FD3BQ50233498-A0A7AD9A-B3E0-4641-8358-5ACDDFC0DEB8Q51737120-163DA658-6234-467E-BF58-F736248D63D8Q57268127-4B05BBAF-4D61-4F17-8A97-9C758384DE1A
P2860
Synthesis of conformationally preorganized and cell-permeable guanidine-based gamma-peptide nucleic acids (gammaGPNAs).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Synthesis of conformationally ...... de nucleic acids (gammaGPNAs).
@en
Synthesis of conformationally ...... ed gamma-peptide nucleic acids
@nl
type
label
Synthesis of conformationally ...... de nucleic acids (gammaGPNAs).
@en
Synthesis of conformationally ...... ed gamma-peptide nucleic acids
@nl
prefLabel
Synthesis of conformationally ...... de nucleic acids (gammaGPNAs).
@en
Synthesis of conformationally ...... ed gamma-peptide nucleic acids
@nl
P2093
P2860
P356
P1476
Synthesis of conformationally ...... de nucleic acids (gammaGPNAs).
@en
P2093
Bichismita Sahu
Danith H Ly
Gerald Zon
Kenneth J Livak
Kira L Lathrop
Sufi M Thomas
Venugopal Chenna
P2860
P304
P356
10.1021/JO802211N
P407
P577
2009-02-01T00:00:00Z